Behavioral Economics and Self-Determination Theory to Change Diabetes Risk (BEST Change)
Public ClinicalTrials.gov record NCT04902326. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Integrating Behavioral Economics and Self-Determination Theory to Advance Patient Engagement in Diabetes Prevention
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Patients with prediabetes can significantly reduce their risk of developing type 2 diabetes mellitus (T2DM) by participating in a Diabetes Prevention Program (DPP) or using metformin, but very few patients with prediabetes engage in these strategies. This randomized controlled trial will compare, among adults with prediabetes, the effectiveness of financial incentives, tailored messages based on self-determination theory (SDT) principles, and the combination of financial incentives plus tailored messages based on SDT principles in decreasing hemoglobin A1c (HbA1c) and weight and in increasing participation in a DPP or use of metformin. Our main hypotheses are that the mean decrease in HbA1c will be greater in the arm that receives a combination of financial incentives plus tailored messages than in the arm that receives generic health education messages, and that the mean decrease in HbA1c will be greater in the arm that receives a combination of financial incentives plus tailored messages than in the arm that receives financial incentives alone and the arm that receives tailored messages alone. The study will also identify moderators and mediators of the effectiveness of the interventions and evaluate facilitators of and barriers to scalability, acceptability, and sustainability of the different interventions.
Study identification
- NCT ID
- NCT04902326
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 380 participants
Conditions and interventions
Conditions
Interventions
- Automated educational text messages Behavioral
- Autonomy-supportive automated educational text messages Behavioral
- Financial incentives Behavioral
- Tailored text messages Behavioral
Behavioral
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 15, 2021
- Primary completion
- Sep 17, 2023
- Completion
- Sep 17, 2023
- Last update posted
- Nov 28, 2024
2021 – 2023
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Michigan | Ann Arbor | Michigan | 48109 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Pre Diabetes trials
Other public records listing Pre Diabetes. Sorted by last update posted; newest first. Not a recommendation.
- NCT07167004: The GRoceries Aimed at Increasing Nutrition Study Recruiting
- NCT06607341: Community Engagement Alliance Against Disparities Active, not recruiting
- NCT05585190: Stand up for Your Health With a Sit-stand Desk Recruiting
- NCT06387797: Primary and Secondary Prevention of Type 2 Diabetes Mellitus in Clark County Active, not recruiting
- NCT04234217: Mechanisms of Prediabetic States in Sleep Apnea Active, not recruiting
- NCT04168372: Fructose: Substrate, Stimulus, or Both? Active, not recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04902326, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 28, 2024 · Synced Sep 1, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04902326 live on ClinicalTrials.gov.